Persistent Asset Partners »

Pliant Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $47k 39k 1.22

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Pliant Therapeutics

Tang Capital Management
Blue Owl Capital Holdings
Vanguard Group
Citadel Advisors
Acadian Asset Management
Jpmorgan Chase & Co
Woodline Partners
Monaco Asset Management SAM
Redmile Group
Prosight Management
BML Capital Management
Marshall Wace
BlackRock
Two Sigma Advisers
UBS Group

View all funds holding Pliant Therapeutics